A detailed history of Blackstone Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Blackstone Inc holds 37,197 shares of RVMD stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,197
Previous 37,197 -0.0%
Holding current value
$1.44 Million
Previous $1.07 Million 12.38%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $126,241 - $182,977
6,081 Added 19.54%
37,197 $805,000
Q4 2022

Feb 14, 2023

BUY
$17.68 - $25.53 $113,647 - $164,106
6,428 Added 26.04%
31,116 $741,000
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $130,950 - $195,000
7,500 Added 43.64%
24,688 $487,000
Q3 2021

Nov 16, 2021

SELL
$23.95 - $33.41 $9.57 Million - $13.3 Million
-399,441 Reduced 95.87%
17,188 $473,000
Q2 2021

Aug 16, 2021

BUY
$29.0 - $47.44 $12.1 Million - $19.8 Million
416,629 New
416,629 $13.2 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.4B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Blackstone Inc Portfolio

Follow Blackstone Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackstone Inc with notifications on news.